Safety and tolerability of Neoral vs Sandimmune: 1-year data in primary renal allograft recipients. Neoral Study Group.
暂无分享，去创建一个
M. Pescovitz | D. Min | D. Hricik | T. Pruett | C. Marsh | D. Wombolt | G. Barone | J. Thompson | E. Vasquez | R. Pollak | R. Wong | C. Bunke | M. Choc | T. Waid | J. Stinson | J. B. Klein | J. Jin